Literature DB >> 11251536

Proliferation and differentiation of prostatic stromal cells.

Y Niu1, Y Xu, J Zhang, J Bai, H Yang, T Ma.   

Abstract

OBJECTIVES: To investigate the effects of androgen, transforming growth factor beta1 (TGF-beta) and basic fibroblast growth factor (bFGF) on the proliferation and differentiation of prostatic stromal cells of the dog in vivo and human stromal cells in vitro.
MATERIALS AND METHODS: Twenty-two dogs had their serum concentration of testosterone and oestradiol determined by radioimmunoassay before and after castration. Light microscopy, transmission electron microscopy and an in situ cell-death assay were carried out successively before and after castration to evaluate prostatic histomorphology. A semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used to evaluate the expression of TGF-beta, bFGF and myosin in the canine prostate tissue after castration. In vitro serum-free cell cultures from human prostatic stroma were established and exposed to dihydrotestosterone (DHT), TGF-beta and bFGF in various concentrations. The proliferation of the cell cultures was detected by the tetrazolium assay. The differentiation from fibroblasts to smooth muscle cells (SMCs) was deduced by measuring the expression of SMC-specific proteins (myosin and smoothelin) using immunohistochemistry and RT-PCR.
RESULTS: Castration resulted in a significant decrease in circulating testosterone levels (P < 0.01), but did not affect the circulating oestradiol levels (P > 0.05). The prostatic stromal cells, including SMCs and fibroblasts, diminished and underwent a serial pathological change of atrophy and apoptosis after castration. The atrophic cells were filled with intracellular lipofuscin. The expression of SMC myosin declined after castration, coincident with the increase in TGF-beta mRNA level and decline in bFGF mRNA. In vitro, TGF-beta inhibited the growth of human prostatic stromal cells during exponential growth, while enhancing myosin staining and stimulating the expression of smoothelin in confluent cultured stromal cells. bFGF stimulated the growth of the culture and inhibited the expression of smoothelin. DHT caused a weak increase in the proliferation and expression of SMC-specific proteins (P < 0.05). However, DHT and bFGF together stimulated the proliferation of stromal cells significantly more than either agent alone (P < 0.01). The combination of DHT and TGF-beta greatly enhanced the expression of SMC-specific proteins (P < 0.01), more strongly than either alone (P < 0.01).
CONCLUSIONS: The whole prostate gland is an androgen-sensitive organ, with both the epithelium and stroma under the control of androgen. Androgen may direct the proliferation and differentiation of prostatic stromal cells by regulating the expression of TGF-beta and bFGF. Thus DHT, TGF-beta and bFGF may have important roles in regulating stromal cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251536     DOI: 10.1046/j.1464-410x.2001.00103.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

1.  Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.

Authors:  Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Carlo Vicentini; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-14       Impact factor: 4.553

2.  Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.

Authors:  Lance W Middleton; Zhewei Shen; Sushama Varma; Anna S Pollack; Xue Gong; Shirley Zhu; Chunfang Zhu; Joseph W Foley; Sujay Vennam; Robert T Sweeney; Karen Tu; Jewison Biscocho; Okyaz Eminaga; Rosalie Nolley; Robert Tibshirani; James D Brooks; Robert B West; Jonathan R Pollack
Journal:  JCI Insight       Date:  2019-05-16

3.  Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.

Authors:  Xinhua Zhang; Ning Zang; Yu Wei; Jin Yin; Ruobing Teng; Allen Seftel; Michael E Disanto
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

Review 4.  Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

5.  Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.

Authors:  Wei Zhou; Irwin Park; Michael Pins; James M Kozlowski; Borko Jovanovic; Ju Zhang; Chung Lee; Kenneth Ilio
Journal:  Endocrinology       Date:  2003-07-24       Impact factor: 4.736

6.  Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor.

Authors:  Yuanjie Niu; Juan Wang; Zhiqun Shang; Shu-Pin Huang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

7.  Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.

Authors:  Motoaki Saito; Panagiota Tsounapi; Ryo Oikawa; Shogo Shimizu; Masashi Honda; Takehiro Sejima; Yukako Kinoshita; Shuhei Tomita
Journal:  Sci Rep       Date:  2014-01-22       Impact factor: 4.379

8.  The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates.

Authors:  Alexander B Opoku-Acheampong; Jamie N Henningson; Brian L Lindshield
Journal:  Heliyon       Date:  2017-07-24

9.  Mangosteen pericarp components alleviate progression of prostatic hyperplasia and mitochondrial dysfunction in rats.

Authors:  Hui-Hsuan Tsai; Chia-Wen Chen; Pei-Ling Yu; Yu-Ling Lin; Rong-Hong Hsieh
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.